{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T19:36:56Z","timestamp":1788550616999,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T00:00:00Z","timestamp":1557878400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T00:00:00Z","timestamp":1557878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001861","name":"Forskningsr\u00e5det f\u00f6r Arbetsliv och Socialvetenskap","doi-asserted-by":"publisher","award":["Grant # SFR 92-0244: 1b"],"award-info":[{"award-number":["Grant # SFR 92-0244: 1b"]}],"id":[{"id":"10.13039\/501100001861","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swedish Prison and Probation Service","award":["52-2007-28104"],"award-info":[{"award-number":["52-2007-28104"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12888-019-2098-3","type":"journal-article","created":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T09:07:55Z","timestamp":1557911275000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Prediction of psychiatric comorbidity on premature death in a cohort of patients with substance use disorders: a 42-year follow-up"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2586-4951","authenticated-orcid":false,"given":"Mats","family":"Fridell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"B\u00e4ckstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Hesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Krantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Perrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nyhl\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,15]]},"reference":[{"key":"2098_CR1","volume-title":"Mortality among drug users in Europe: New and old challenges for public health","author":"EMCDDA","year":"2015","unstructured":"EMCDDA. European Monitoring Centre for Drugs and Drug Addiction. In: Mortality among drug users in Europe: New and old challenges for public health; 2015. \n                    Http:\/\/www.emcdda.europa.eu\/publications\/emcdda-papers\/mortality-among-drug-users-in-Europe\n                    \n                  ."},{"key":"2098_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1600-0447.1997.tb10147.x","volume":"96","author":"A Fugelstad","year":"1997","unstructured":"Fugelstad A, Annell A, Rajs J, \u00c5gren G. Mortality and causes and manner of death among drug addicts in Stockholm during the period 1981\u20131992. Acta Psych Scand. 1997;96:169\u201375.","journal-title":"Acta Psych Scand"},{"issue":"3","key":"2098_CR3","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1360-0443.2006.01714.x","volume":"102","author":"A Fugelstad","year":"2007","unstructured":"Fugelstad A, Stenbacka M, Leifman A, Nylander M. Thiblin. Methadone. i. Maintenance treatment: the balance between life-saving treatment and fatal. Ii. Poisonings. Addiction. 2007;102(3):406\u201312.","journal-title":"Addiction"},{"issue":"4","key":"2098_CR4","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jsat.2012.09.007","volume":"44","author":"M Arendt","year":"2013","unstructured":"Arendt M, Munk-J\u00f6rgensen P, Sher L, Jensen SO. Mortality following treatment for cannabis use disorders: predictors and causes. J Subst Abuse Treatm. 2013; Apr;44(4):400\u20136.","journal-title":"J Subst Abuse Treatm"},{"key":"2098_CR5","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2471\/BLT.12.108282","volume":"91","author":"BM Mathers","year":"2013","unstructured":"Mathers BM, Degenhardt L, Bucello C, Lemon J, Wiessing L, Hickman M. Mortality among people who inject drugs: a systematic review and meta-analysis. Bull World Health Organ. 2013;91:102\u201323.","journal-title":"Bull World Health Organ"},{"issue":"1","key":"2098_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1360-0443.2004.00602.x","volume":"99","author":"A Bartu","year":"2004","unstructured":"Bartu A, Freeman NC, Gawthorne GS, Codde JP, Holman CD. Mortality in. i. a cohort of opiate and amphetamine users in Perth, Western Australia. Ii. Addiction. 2004;99(1):53\u201360.","journal-title":"Addiction."},{"key":"2098_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jflm.2011.01.003","volume":"18","author":"A Nyhl\u00e9n","year":"2011","unstructured":"Nyhl\u00e9n A, Fridell M, Hesse M, Krantz P. Causes of premature mortality in. Swedish drug abusers: a prospective longitudinal study 1970-2006. Ii. J Forensic Legal Med. 2011;18:66\u201372.","journal-title":"J Forensic Legal Med"},{"key":"2098_CR8","volume-title":"The ICD-10 classification of mental and behavioral disorders and somatic diseases","author":"World Health Organization","year":"1993","unstructured":"World Health Organization. The ICD-10 classification of mental and behavioral disorders and somatic diseases. Geneva: WHO; 1993."},{"key":"2098_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1521\/pedi.1995.9.2.83","volume":"9","author":"M First","year":"1995","unstructured":"First M, Spitzer R, Gibbon M, Williams J. The structured clinical interview for DSM-III-R personality disorders [SCID-II]. I: description. J Personal Disorder. 1995;9:83\u201391.","journal-title":"J Personal Disorder"},{"key":"2098_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000346781","volume":"20","author":"H Waal","year":"2014","unstructured":"Waal H, Gossop M. Making sense of differing overdose Mortality: contributions to improved understanding of European patterns. Eur Addict Res. 2014;20:8\u201315.","journal-title":"Eur Addict Res"},{"key":"2098_CR11","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1046\/j.1360-0443.2002.00179.x","volume":"97","author":"CA Buster","year":"2002","unstructured":"Buster CA, van Brussel GH, van den Brink W. An increase in overdose mortality during the first 2 weeks after entering or re-entering methadone. Treatment in Amsterdam. Addiction. 2002;97:993\u20131001.","journal-title":"Addiction."},{"issue":"2","key":"2098_CR12","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1046\/j.1360-0443.1999.9422216.x","volume":"94","author":"GK Hulse","year":"1999","unstructured":"Hulse GK, English DR, Milne E, Holman CD. The quantification of mortality resulting from the regular use of illicit opiates. Addiction. 1999;94(2):221\u20139.","journal-title":"Addiction"},{"issue":"1","key":"2098_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1046\/j.1360-0443.2002.00079.x","volume":"97","author":"M Gossop","year":"2002","unstructured":"Gossop M, Stewart D, Treacy S, Marsden J. A prospective study of mortality among drug misusers during a 4-year period after seeking treatment. Addiction. 2002;97(1):39\u201347.","journal-title":"Addiction"},{"key":"2098_CR14","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1177\/1403494814525006","volume":"42","author":"A Fugelstad","year":"2014","unstructured":"Fugelstad A, Annell A, \u00c5gren G. Long-term mortality and causes of death among hospitalized Swedish drug users. Scand J Public Health. 2014;42:364\u20132.","journal-title":"Scand J Public Health"},{"key":"2098_CR15","volume-title":"Drug related deaths in Sweden \u2013 estimations of trends, effects of changes in recording practices and studies of drug patterns. CAN Report no 158","author":"H Leifman","year":"2016","unstructured":"Leifman H. Drug related deaths in Sweden \u2013 estimations of trends, effects of changes in recording practices and studies of drug patterns. CAN Report no 158. 2016. URN: NBN: se: can-2016-4 [Pdf]."},{"issue":"8","key":"2098_CR16","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1111\/add.12456","volume":"209","author":"S Darke","year":"2014","unstructured":"Darke S, Farrell M. Would legalizing illicit opioids reduce overdose fatalities? Implications from a natural experiment. Addiction. 2014;209(8):1237\u201342.","journal-title":"Addiction"},{"key":"2098_CR17","volume-title":"Suchtmedizin \u2013 Konzepte, Strategien und therapeutisches management [addiction medicine \u2013 concepts, strategies and therapeutic management]","author":"U Uchtenhagen","year":"2000","unstructured":"Uchtenhagen U, Zieglg\u00e4nsberger W. Suchtmedizin \u2013 Konzepte, Strategien und therapeutisches management [addiction medicine \u2013 concepts, strategies and therapeutic management]. M\u00fcnchen: Urban & Fischer Verlag; 2000."},{"key":"2098_CR18","volume-title":"Personlighet och drogmissbruk \u2013 En forsknings\u00f6versikt. [Personality and Drug Abuse \u2013 A Research Review]","author":"M Fridell","year":"1991","unstructured":"Fridell M. Personlighet och drogmissbruk \u2013 En forsknings\u00f6versikt. [Personality and Drug Abuse \u2013 A Research Review]. Stockholm: CAN, PM-serie 10; 1991."},{"key":"2098_CR19","unstructured":"Fridell M, Hesse M, Nyhl\u00e9n A. Substance dependence and psychiatric disorders: a cohort study of prevalence, psychiatric disorders and personality disorders among patients with dependence on narcotic drug. [Long-term outcome in substance use, criminality, treatment consumption and mortality; In Swedish]. Forskning och utv\u00e4rdering inom kriminalv\u00e5rden. Project 2007: 9. Kriminalv\u00e5rden; 2015."},{"issue":"3","key":"2098_CR20","first-page":"122","volume":"61","author":"F Schifano","year":"2010","unstructured":"Schifano F, Corkery J, Naidoo V, Oyefeso A, Ghodse H. Overview of i. amphetamine-type stimulant mortality data in UK, 1997\u20132007. Ii. Neuro-psychobiology. 2010;61(3):122\u201330.","journal-title":"Neuro-psychobiology."},{"key":"2098_CR21","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/j.1465-3362.2010.00196.x","volume":"29","author":"P Kittirattanapaiboon","year":"2010","unstructured":"Kittirattanapaiboon P, Mahatnirunkul S, Booncharoen H, Thummawomg P, Dumrongchai U, Chutha W. Long-term outcomes in methamphetamine psychosis patients after first hospitalization. Drug and Alc Review. 2010;29:456\u201361.","journal-title":"Drug and Alc Review"},{"issue":"8574","key":"2098_CR22","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/S0140-6736(87)92620-1","volume":"330","author":"Sven Andr\u00e9asson","year":"1987","unstructured":"Andreasson S, Allebeck P, Engstrom A, Rydberg U. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet. 1987;(2, 8574):1483\u20136.","journal-title":"The Lancet"},{"key":"2098_CR23","doi-asserted-by":"crossref","unstructured":"Andreasson S, Engstrom A, Allebeck P, Rydberg U. Cannabis and mortality among young men. A Longitudinal study of Swedish conscripts. Scand J Soc Med. 1990;18(1):9-15.","DOI":"10.1177\/140349489001800102"},{"issue":"8","key":"2098_CR24","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1176\/appi.ajp.2016.14050637","volume":"173","author":"Edison Manrique-Garcia","year":"2016","unstructured":"Manrique-Garcia E, Ponce de Leon A, Dalman C, Andr\u00e9asson S, Allebeck P. Cannabis, psychosis, and mortality. A cohort study of 50,373 Swedish men. Am J Psychiatry. 2016;173(8):790-8.","journal-title":"American Journal of Psychiatry"},{"key":"2098_CR25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jsat.2006.07.005","volume":"32","author":"M Arendt","year":"2007","unstructured":"Arendt M, Rosenberg R, Foldager L, Pertoa G, Munk-J\u00f6rgensen P. Psychopathology among cannabis-dependent treatment seekers and association i. with later substance abuse treatment. J Subst Abuse Treat. 2007;32:113\u20139.","journal-title":"J Subst Abuse Treat"},{"key":"2098_CR26","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1034\/j.1600-0447.2000.102006432.x","volume":"102","author":"SP Hansen","year":"2000","unstructured":"Hansen SP, Munk-Jorgensen B, Guldbaek N, et al. Psychoactive substance use disorders among psychiatric inpatients. Acta Psych Scand. 2000;102:432\u20138.","journal-title":"Acta Psych Scand"},{"key":"2098_CR27","volume-title":"In: New directions for mental health services","author":"RE Drake","year":"1996","unstructured":"Drake RE, Mueser KT. Dual diagnoses of major mental illness and substance abuse. In: In: New directions for mental health services. San Francisco: Jossey-Bass; 1996."},{"issue":"7","key":"2098_CR28","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S0924-9338(99)00234-5","volume":"14","author":"A Dalmau","year":"1999","unstructured":"Dalmau A, Bergman B. Brismar B. psychotic disorders among inpatients with abuse of cannabis, amphetamine and opiates. Do dopaminergic stimulants facilitate psychiatric illness? Eur Psych. 1999;14(7):366\u201371.","journal-title":"Eur Psych"},{"key":"2098_CR29","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/1471-244X-13-336","volume":"13","author":"B Bihlar Muld","year":"2013","unstructured":"Bihlar Muld B, Jokinen J, B\u00f6lte S, Hirvikoski T. Attention deficit\/hyperactivity disorders with co-existing substance use disorder is characterized by early antisocial behavior and poor cognitive skills. BMC Psychiatry. 2013;13:336\u201347.","journal-title":"BMC Psychiatry"},{"key":"2098_CR30","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1600-0447.2004.00445.x","volume":"111","author":"HJ S\u00f6rensen","year":"2005","unstructured":"S\u00f6rensen HJ, Jepsen PW, Haastrup S, Juel K. Drug-use pattern, comorbid i. psychosis and mortality in people with a history of opioid addiction. Acta Psych Scand. 2005;111:244\u20139.","journal-title":"Acta Psych Scand"},{"key":"2098_CR31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jsat.2010.08.002","volume":"40","author":"S Dawe","year":"2011","unstructured":"Dawe S, Geppert L, Occhipinti S, Klinswell W. A comparison of the symptoms and short-term clinical course in inpatients with substance-induced psychosis and primary psychosis. J Subst Abus Treat. 2011;40:95\u2013101.","journal-title":"J Subst Abus Treat"},{"key":"2098_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000173006","volume":"15","author":"I Jansson","year":"2009","unstructured":"Jansson I, Hesse M, Fridell M. Influence of personality disorder features on social functioning in substance abusing women five year after compulsive residential treatment. Eur Addiction Res. 2009;15:23\u201331.","journal-title":"Eur Addiction Res"},{"key":"2098_CR33","first-page":"351","volume-title":"Comorbidity in Europe. ECCAS monograph series no 4","author":"M Nilsson","year":"2006","unstructured":"Nilsson M, Fridell M, Griffiths P. Comorbidity \u2013 developing of a European perspective. In: Baldachino P, Corkerey J, editors. Comorbidity in Europe. ECCAS monograph series no 4. Lisboa: EMCDDA; 2006. p. 351\u201363."},{"key":"2098_CR34","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/S0924-9338(01)00578-8","volume":"16","author":"V Verheul","year":"2001","unstructured":"Verheul V. Comorbidity of personality disorders in individuals with substance use disorders. Eur Psychiatry. 2001;16:274\u201382.","journal-title":"Eur Psychiatry"},{"issue":"6","key":"2098_CR35","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.addbeh.2008.01.001","volume":"33","author":"M Fridell","year":"2008","unstructured":"Fridell M, Hesse M, Jaeger MM, K\u00fchlhorn E. Antisocial personality disorder as a predictor of criminal behavior in a longitudinal study of a cohort of abusers of several classes of drugs: relation to type of substance and type of crime. Addict Behav. 2008;33(6):799\u2013811.","journal-title":"Addict Behav"},{"key":"2098_CR36","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1001\/archpsyc.61.4.361","volume":"61","author":"BF Grant","year":"2004","unstructured":"Grant BF, Stinson FS, Dawson DA, Chou AP, Ruan J, Pickering RP. Co-occurrence or 12-month alcohol and drug use disorders and personality disorders in the United States. Results from the National Epidemiologic Survey on alcohol and related conditions. Arch of Gen Psych. 2004;61:361\u20138.","journal-title":"Arch of Gen Psych"},{"key":"2098_CR37","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1001\/archpsyc.61.8.807","volume":"61","author":"B Grant","year":"2004","unstructured":"Grant B, Stinson FS, Dawson DA, Chou AP, Ruan J, Pickering RP. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on alcohol and related conditions. Arch of Gen Psych. 2004;61:807\u201316.","journal-title":"Arch of Gen Psych."},{"key":"2098_CR38","volume-title":"Heavy drug use, A special report for counties and municipalities of the 1979 study. Swedish National Institute of Public Health, DsS 1980:5","author":"UNO","year":"1980","unstructured":"UNO. Heavy drug use, A special report for counties and municipalities of the 1979 study. Swedish National Institute of Public Health, DsS 1980:5. Stockholm: Liber; 1980."},{"issue":"3","key":"2098_CR39","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0740-5472(91)90008-X","volume":"8","author":"GW Berglund","year":"1991","unstructured":"Berglund GW, Bergmark B, Bj\u00f6rling B, Gr\u00f6nblad L, Lindberg S, Oscarsson L, Olsson B. Segraeus. The SWEDATE project: interaction between treatment, client background and outcome in a one-year follow-up. J Subst Abus Treat. 1991;8(3):161\u20139.","journal-title":"J Subst Abus Treat"},{"key":"2098_CR40","volume-title":"MAX-project \u2013 Det tunga narkotikamissbrukets omfattning i Sverige 1998. The max project. Report 3","author":"B Olsson","year":"2001","unstructured":"Olsson B, Adamsson Wahren C, Byqvist S. MAX-project \u2013 Det tunga narkotikamissbrukets omfattning i Sverige 1998. The max project. Report 3. Stockholm: Swedish Council for the Information on Alcohol and Drugs [CAN]; 2001."},{"key":"2098_CR41","volume-title":"Annual Report","author":"Swedish Council for the Information on Alcohol and Drugs","year":"2014","unstructured":"Swedish Council for the Information on Alcohol and Drugs. Annual Report. Stockholm: CAN; 2014."},{"key":"2098_CR42","unstructured":"Swedish Central Bureau of Statistics, SCB Sweden, 2014. \n                    http:\/\/www.scb.se\n                    \n                  ."},{"issue":"4","key":"2098_CR43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jcfm.2004.11.003","volume":"12","author":"LJ Degenhardt","year":"2005","unstructured":"Degenhardt LJ, Roxburgh A, Barker B. Underlying causes of cocaine, amphetamine and opioid related deaths in Australia. J Clin Forensic Med. 2005;12(4):187\u201395.","journal-title":"J Clin Forensic Med"},{"key":"2098_CR44","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1192\/bjp.177.2.149","volume":"177","author":"M Ruggeri","year":"2000","unstructured":"Ruggeri M, Leese M, Thornicroft G, Bisoffi G, Tansella M. Definition and pre- valence of severe and persistent mental illness. Brit J Psych. 2000;177:149\u201355.","journal-title":"Brit J Psych"},{"issue":"2","key":"2098_CR45","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1027\/1015-5759.22.2.104","volume":"22","author":"Mats Fridell","year":"2006","unstructured":"Fridell M, Hesse M. Clinical diagnosis and SCID-II assessment of DSM-III-R personality disorders. Eur J Psychol Assessm. 2006;22(2).","journal-title":"European Journal of Psychological Assessment"},{"key":"2098_CR46","unstructured":"IBM, Corp. IBM SPSS Statistics for Windows, Version 25, Armonk: IBM Corp.; 2017."},{"issue":"6","key":"2098_CR47","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1002\/sim.2655","volume":"26","author":"M Pintilie","year":"2007","unstructured":"Pintilie M. Analysing and interpreting competing risk data. Stat Med. 2007;26(6):1360\u20137.","journal-title":"Stat Med"},{"issue":"1","key":"2098_CR48","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1465-3362.2009.00075.x","volume":"29","author":"M Stenbacka","year":"2010","unstructured":"Stenbacka M, Leifman A, Romelsj\u00f6 A. Mortality and cause of death among. 1705 illicit drug users: A follow up. Drug Alc Rev. 2010;29(1):21\u20137.","journal-title":"Drug Alc Rev"},{"key":"2098_CR49","volume-title":"Akuta narkotikarelaterade d\u00f6dsfall 1994\u20132010. [development of acute drug-related deaths 1994\u20132010.] Karolinska Institutet. Institute of Clinical Neuroscience","author":"A Fugelstad","year":"2012","unstructured":"Fugelstad A. Akuta narkotikarelaterade d\u00f6dsfall 1994\u20132010. [development of acute drug-related deaths 1994\u20132010.] Karolinska Institutet. Institute of Clinical Neuroscience. Stockholm: Swedish National Institute of Public Health; 2012."},{"key":"2098_CR50","unstructured":"Andersson B, Fridell M, Nilsson K, Tunving K. Sjuttiotalets narkomaner \u2013 Patienter v\u00e5rdade vid St Lars sjukhus 1970\u20131978. Narcotic abusers of the 1970s. Patients treated at St Lars hospital 1970\u20131978. (Swedish only). Dept of psychiatry & neurochemistry, Lund University."},{"key":"2098_CR51","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1192\/bjp.bp.111.094904","volume":"200","author":"N Markkula","year":"2012","unstructured":"Markkula N, H\u00e4rk\u00e4nen T, Per\u00e4l\u00e4 K, Partii K, Pe\u00f1a S, Koskinen S, L\u00f6nnqvist J, Suvisaari J, Saarni SI. Mortality in people with depressive, anxiety and alcohol use disorders in Finland. The Brit J of Psych. 2012;200:143\u20139.","journal-title":"The Brit J of Psych"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-019-2098-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12888-019-2098-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-019-2098-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T23:14:40Z","timestamp":1589411680000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-019-2098-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,15]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2098"],"URL":"https:\/\/doi.org\/10.1186\/s12888-019-2098-3","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,15]]},"assertion":[{"value":"5 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethical Committee of Lund University [LU 22\/1983 and Dnr 587\/2005]. Patients provided written consents.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no financial or other conflicts of interests in relation to this manuscript. The funders have no say with regard to the analyses, interpretation, or decision to submit the manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"150"}}